<DOC>
	<DOCNO>NCT02327013</DOCNO>
	<brief_summary>The purpose determine effect vortioxetine treatment ADHD symptom adult patient ADHD 12 week study .</brief_summary>
	<brief_title>Investigating Effect Vortioxetine Adult ADHD Patients</brief_title>
	<detailed_description>The study consist 2 stage 6-weeks .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>The patient age ≥18 year ≤55 year . The patient willing able attend study appointment within specified time window . The patient outpatient . The patient diagnose primary diagnosis ADHD accord DSM5™ classification . The patient AISRS total score ≥24 . The patient CGIS rating ≥4 ( moderately ill bad ) . The patient previously treat vortioxetine . The patient current psychiatric disorder ( DSMIVTR™ criterion ) , ADHD , assess use Mini International Neuropsychiatric Interview ( MINI ) . The patient know firstdegree relative bipolar disorder . The patient suffers intellectual disability evaluate Wechsler Abbreviated Scale Intelligence ( WASI ) II vocabulary matrix . The patient suffer organic mental disorder , mental disorder due general medical condition ( DSM5™ criterion ) . The patient report current use , test positive , drug abuse ( opiate , methadone , cocaine , amphetamine [ include ecstasy ] , barbiturate , benzodiazepine , cannabinoids ) . If patient test positive opiate due incidental use codeine contain medication , assess clinical interview , drug screen may repeat three week later retest result must available central laboratory late Visit 2 negative patient eligible enrolment . If patient test positive amphetamine due his/her ADHD current treatment , confirm clinical interview , patient eligible enrolment provide treatment discontinue two week prior Baseline Visit . The patient history two prior fail ( &lt; 50 % improvement symptom ) adequate trial ADHD treatment . The patient disorder treatment take priority treatment ADHD likely interfere study treatment impair treatment compliance . The patient history moderate severe head trauma neurological disorder systemic medical disease , investigator 's opinion , likely affect central nervous system function . The patient attempt suicide within last 6 month significant risk suicide ( either opinion Investigator define `` yes '' suicidal ideation question 4 5 answer `` yes '' suicidal behaviour ColumbiaSuicide Rating Scale ( CSSRS ) within last 12 month ) . Other protocol define inclusion exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>